These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 11773178)

  • 1. Outcomes and cost-effectiveness of alternative staging strategies for non-small-cell lung cancer.
    Esnaola NF; Lazarides SN; Mentzer SJ; Kuntz KM
    J Clin Oncol; 2002 Jan; 20(1):263-73. PubMed ID: 11773178
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cost-effectiveness of routine mediastinoscopy in computed tomography- and positron emission tomography-screened patients with stage I lung cancer.
    Meyers BF; Haddad F; Siegel BA; Zoole JB; Battafarano RJ; Veeramachaneni N; Cooper JD; Patterson GA
    J Thorac Cardiovasc Surg; 2006 Apr; 131(4):822-9; discussion 822-9. PubMed ID: 16580440
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Positron emission tomography with selected mediastinoscopy compared to routine mediastinoscopy offers cost and clinical outcome benefits for pre-operative staging of non-small cell lung cancer.
    Yap KK; Yap KS; Byrne AJ; Berlangieri SU; Poon A; Mitchell P; Knight SR; Clarke PC; Harris A; Tauro A; Rowe CC; Scott AM
    Eur J Nucl Med Mol Imaging; 2005 Sep; 32(9):1033-40. PubMed ID: 15875178
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cost-effectiveness of hybrid PET/CT for staging of non-small cell lung cancer.
    Schreyögg J; Weller J; Stargardt T; Herrmann K; Bluemel C; Dechow T; Glatting G; Krause BJ; Mottaghy F; Reske SN; Buck AK
    J Nucl Med; 2010 Nov; 51(11):1668-75. PubMed ID: 21051648
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cost-minimization analysis of alternative diagnostic approaches in a modeled patient with non-small cell lung cancer and subcarinal lymphadenopathy.
    Harewood GC; Wiersema MJ; Edell ES; Liebow M
    Mayo Clin Proc; 2002 Feb; 77(2):155-64. PubMed ID: 11838649
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Endoscopic ultrasound-guided fine-needle aspiration in patients with non-small cell lung cancer and prior negative mediastinoscopy.
    Eloubeidi MA; Tamhane A; Chen VK; Cerfolio RJ
    Ann Thorac Surg; 2005 Oct; 80(4):1231-9. PubMed ID: 16181845
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cost-effectiveness analysis of strategies introducing integrated ¹⁸F-FDG PET/CT into the mediastinal lymph node staging of non-small-cell lung cancer.
    Han Y; Xiao H; Zhou Z; Yuan M; Zeng Y; Wu H; Fang Y
    Nucl Med Commun; 2015 Mar; 36(3):234-41. PubMed ID: 25460305
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Should mediastinoscopy actually be incorporated into the FDG PET strategy for patients with non-small cell lung carcinoma?
    Hayashi K; Abe K; Yano F; Watanabe S; Iwasaki Y; Kosuda S
    Ann Nucl Med; 2005 Jul; 19(5):393-8. PubMed ID: 16164196
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The optimality of different strategies for supplemental staging of non-small-cell lung cancer: a health economic decision analysis.
    Søgaard R; Fischer BM; Mortensen J; Rasmussen TR; Lassen U
    Value Health; 2013; 16(1):57-65. PubMed ID: 23337216
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cost-benefit of minimally invasive staging of non-small cell lung cancer: a decision tree sensitivity analysis.
    Steinfort DP; Liew D; Conron M; Hutchinson AF; Irving LB
    J Thorac Oncol; 2010 Oct; 5(10):1564-70. PubMed ID: 20871261
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Carboplatin plus pemetrexed offers superior cost-effectiveness compared to pemetrexed in patients with advanced non-small cell lung cancer and performance status 2.
    Schluckebier L; Garay OU; Zukin M; Ferreira CG
    Lung Cancer; 2015 Sep; 89(3):274-9. PubMed ID: 26143106
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 18FDG-PET-CT in the follow-up of non-small cell lung cancer patients after radical radiotherapy with or without chemotherapy: an economic evaluation.
    van Loon J; Grutters JP; Wanders R; Boersma L; Dingemans AM; Bootsma G; Geraedts W; Pitz C; Simons J; Brans B; Snoep G; Hochstenbag M; Lambin P; De Ruysscher D
    Eur J Cancer; 2010 Jan; 46(1):110-9. PubMed ID: 19944595
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Decision tree sensitivity analysis for cost-effectiveness of FDG-PET in the staging and management of non-small-cell lung carcinoma.
    Gambhir SS; Hoh CK; Phelps ME; Madar I; Maddahi J
    J Nucl Med; 1996 Sep; 37(9):1428-36. PubMed ID: 8790186
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The cost-effectiveness and cost-utility of high-dose palliative radiotherapy for advanced non-small-cell lung cancer.
    Coy P; Schaafsma J; Schofield JA
    Int J Radiat Oncol Biol Phys; 2000 Nov; 48(4):1025-33. PubMed ID: 11072159
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Risk factor analysis of mediastinal lymph node metastasis in non-small cell lung cancer patients and the strategy of mediastinoscopy prior to surgery].
    Wang X; Zheng L; Zhang SY; Xie ZM; Yu H; Su XD; Wang JY; Huang ZF; Yang MT; Rong TH
    Zhonghua Zhong Liu Za Zhi; 2009 Jun; 31(6):456-9. PubMed ID: 19950559
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Is FDG PET/CT cost-effective for pre-operation staging of potentially operative non-small cell lung cancer? - From Chinese healthcare system perspective.
    Wang YT; Huang G
    Eur J Radiol; 2012 Aug; 81(8):e903-9. PubMed ID: 22698711
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A comparison of surgical intervention and stereotactic body radiation therapy for stage I lung cancer in high-risk patients: a decision analysis.
    Puri V; Crabtree TD; Kymes S; Gregory M; Bell J; Bradley JD; Robinson C; Patterson GA; Kreisel D; Krupnick AS; Meyers BF
    J Thorac Cardiovasc Surg; 2012 Feb; 143(2):428-36. PubMed ID: 22169443
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Routine mediastinoscopy and esophageal ultrasound fine-needle aspiration in patients with non-small cell lung cancer who are clinically N2 negative: a prospective study.
    Cerfolio RJ; Bryant AS; Eloubeidi MA
    Chest; 2006 Dec; 130(6):1791-5. PubMed ID: 17166998
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mediastinoscopy might not be necessary in patients with non-small cell lung cancer with mediastinal lymph nodes having a maximum standardized uptake value of less than 5.3.
    Lee BE; Redwine J; Foster C; Abella E; Lown T; Lau D; Follette D
    J Thorac Cardiovasc Surg; 2008 Mar; 135(3):615-9. PubMed ID: 18329480
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Endoscopic ultrasound added to mediastinoscopy for preoperative staging of patients with lung cancer.
    Annema JT; Versteegh MI; Veseliç M; Welker L; Mauad T; Sont JK; Willems LN; Rabe KF
    JAMA; 2005 Aug; 294(8):931-6. PubMed ID: 16118383
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.